A detailed history of Wealth Bridge Investment Counsel Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wealth Bridge Investment Counsel Inc. holds 70,605 shares of GILD stock, worth $6.54 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares
70,605
Previous 70,955 0.49%
Holding current value
$6.54 Million
Previous $4.87 Million 21.61%
% of portfolio
2.1%
Previous 1.86%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$66.59 - $83.99 $23,306 - $29,396
-350 Reduced 0.49%
70,605 $5.92 Million
Q2 2024

Jul 16, 2024

SELL
$63.15 - $72.88 $195,765 - $225,928
-3,100 Reduced 4.19%
70,955 $4.87 Million
Q1 2024

Apr 19, 2024

SELL
$71.58 - $87.29 $232,635 - $283,692
-3,250 Reduced 4.2%
74,055 $5.43 Million
Q4 2023

Jan 17, 2024

SELL
$73.27 - $83.09 $62,279 - $70,626
-850 Reduced 1.09%
77,305 $6.26 Million
Q3 2023

Oct 17, 2023

SELL
$73.94 - $80.67 $18,485 - $20,167
-250 Reduced 0.32%
78,155 $5.86 Million
Q2 2023

Jul 26, 2023

BUY
$76.01 - $86.7 $15,202 - $17,340
200 Added 0.26%
78,405 $6.04 Million
Q1 2023

Apr 18, 2023

SELL
$77.31 - $88.08 $65,713 - $74,868
-850 Reduced 1.08%
78,205 $6.49 Million
Q4 2022

Feb 02, 2023

BUY
$62.32 - $89.47 $105,944 - $152,099
1,700 Added 2.2%
79,055 $6.79 Million
Q3 2022

Oct 13, 2022

BUY
$59.54 - $68.01 $196,482 - $224,433
3,300 Added 4.46%
77,355 $4.77 Million
Q2 2022

Jul 26, 2022

SELL
$57.72 - $65.01 $46,176 - $52,008
-800 Reduced 1.07%
74,055 $4.58 Million
Q1 2022

Apr 05, 2022

SELL
$57.92 - $72.58 $15,059 - $18,870
-260 Reduced 0.35%
74,855 $4.45 Million
Q4 2021

Jan 24, 2022

BUY
$64.88 - $73.64 $84,344 - $95,732
1,300 Added 1.76%
75,115 $5.45 Million
Q3 2021

Oct 20, 2021

SELL
$67.69 - $73.03 $6,769 - $7,303
-100 Reduced 0.14%
73,815 $5.16 Million
Q2 2021

Aug 03, 2021

BUY
$63.47 - $69.35 $174,542 - $190,712
2,750 Added 3.86%
73,915 $5.09 Million
Q1 2021

Apr 26, 2021

BUY
$60.0 - $68.46 $15,000 - $17,115
250 Added 0.35%
71,165 $4.6 Million
Q4 2020

Feb 03, 2021

BUY
$56.65 - $64.55 $362,560 - $413,120
6,400 Added 9.92%
70,915 $4.13 Million
Q3 2020

Oct 30, 2020

BUY
$62.1 - $78.08 $66,757 - $83,936
1,075 Added 1.69%
64,515 $4.08 Million
Q2 2020

Aug 06, 2020

BUY
$72.34 - $84.0 $50,638 - $58,800
700 Added 1.12%
63,440 $6.65 Million
Q1 2020

Apr 20, 2020

BUY
$62.63 - $80.22 $93,945 - $120,330
1,500 Added 2.45%
62,740 $4.69 Million
Q4 2019

Jan 23, 2020

BUY
$61.62 - $67.78 $3.77 Million - $4.15 Million
61,240 New
61,240 $3.98 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Wealth Bridge Investment Counsel Inc. Portfolio

Follow Wealth Bridge Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Bridge Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wealth Bridge Investment Counsel Inc. with notifications on news.